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abstract
 
We describe the functional consequences of mutations in the linker between the second and third
transmembrane segments (M2–M3L) of muscle acetylcholine receptors at the single-channel level. Hydrophobic
 
mutations (Ile, Cys, and Phe) placed near the middle of the linker of the 
 
a
 
 subunit (
 
a
 
S269) prolong apparent
openings elicited by low concentrations of acetylcholine (ACh), whereas hydrophilic mutations (Asp, Lys, and
Gln) are without effect. Because the gating kinetics of the 
 
a
 
S269I receptor (a congenital myasthenic syndrome
 
mutant) in the presence of ACh are too fast, choline was used as the agonist. This revealed an 
 
z
 
92-fold increased
 
gating equilibrium constant, which is consistent with an 
 
z
 
10-fold decreased EC
 
50
 
 in the presence of ACh. With
choline, this mutation accelerates channel opening 
 
z
 
28-fold, slows channel closing 
 
z
 
3-fold, but does not affect
agonist binding to the closed state. These ratios suggest that, with ACh, 
 
a
 
S269I acetylcholine receptors open at a
 
rate of 
 
z
 
1.4 
 
3
 
 10
 
6
 
 s
 
2
 
1
 
 and close at a rate of 
 
z
 
760 s
 
2
 
1
 
. These gating rate constants, together with the measured du-
ration of apparent openings at low ACh concentrations, further suggest that ACh dissociates from the diliganded
open receptor at a rate of 
 
z
 
140 s
 
2
 
1
 
. Ile mutations at positions ﬂanking 
 
a
 
S269 impair, rather than enhance, chan-
nel gating. Inserting or deleting one residue from this linker in the 
 
a
 
 subunit increased and decreased, respec-
tively, the apparent open time approximately twofold. Contrary to the 
 
a
 
S269I mutation, Ile mutations at equiva-
lent positions of the 
 
b
 
, 
 
e
 
, and 
 
d
 
 subunits do not affect apparent open-channel lifetimes. However, in 
 
b
 
 and 
 
e
 
, shift-
ing the mutation one residue to the NH
 
2
 
-terminal end enhances channel gating. The overall results indicate that
this linker is a control element whose hydrophobicity determines channel gating in a position- and subunit-depen-
dent manner. Characterization of the transition state of the gating reaction suggests that during channel opening
the M2–M3L of the 
 
a
 
 subunit moves before the corresponding linkers of the 
 
b
 
 and 
 
e
 
 subunits.
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INTRODUCTION
 
The muscle acetylcholine receptor channel (AChR)
 
1
 
 is
a ligand-activated ion channel that mediates neuromus-
cular transmission in vertebrates (reviewed in Edmonds
et al., 1995). The adult form of the channel consists of
 
ﬁve subunits (
 
a
 
2
 
bde
 
), each having four putative mem-
brane-spanning domains (M1, M2, M3, and M4; re-
viewed in Karlin and Akabas, 1995). This topology is
shared by all members of the superfamily of penta-
meric nicotinoid receptors, which includes muscle and
neuronal nicotinic, 5-HT
 
3
 
, glycine, GABA
 
A
 
, and GABA
 
C
 
receptors (Ortells and Lunt, 1995).
The second transmembrane segment (M2) from
each subunit lines the narrow region of the ion-perme-
ation pathway and is critical for both ion permeation
(Imoto et al., 1988; Villarroel et al., 1991; Cohen et al.,
1992) and gating (Filatov and White, 1995; Labarca et
al., 1995; Ohno et al., 1995; Chen and Auerbach, 1998;
Grosman and Auerbach, 2000a,b) of the channel. The
intracellular projection of M2 (i.e., the linker between
the ﬁrst and second transmembrane segments) has
been shown to contribute to the charge selectivity ﬁlter
of 
 
a
 
7 AChRs (Galzi et al., 1992; Corringer, et al., 1999).
The extracellular projection of M2 (i.e., the linker be-
tween the second and third transmembrane segments,
M2–M3L) has been mainly implicated with gating in
 
a
 
3
 
, 
 
a
 
7
 
, and 
 
b
 
4
 
 subunit-containing AChRs (Campos-Caro
et al., 1996; Rovira et al., 1998, 1999), glycine receptor
 
a
 
1
 
 homomers (Lynch et al., 1997), and GABA
 
C
 
 recep-
tor 
 
r
 
1
 
 homomers (Kusama et al., 1994).
 
The effect of naturally occurring mutations in the M2–
M3L also suggests a role in channel gating. The slow-
channel congenital myasthenic syndrome (SCCMS) mu-
 
tation 
 
a
 
S269I prolongs the AChR’s apparent open time
(Croxen et al., 1997), and the hyperekplexia mutations
 
R271L, R271Q, K276E, and Y279C, in the 
 
a
 
1
 
 subunit of
the glycine receptor, shorten the apparent open time
(Lynch et al., 1997 and references therein; Lewis et al.,
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1998.). In addition, the extracellular location of the M2–
M3L makes it a likely target of drugs and synaptically re-
leased agents. Indeed, residues within or ﬂanking this
loop have been shown to be critical for the modulatory
effects of Zn
 
2
 
1
 
 in GABA
 
A
 
 receptors (Fisher and Mac-
donald, 1998), and of ethanol and volatile anesthetics in
GABA
 
A
 
 and glycine receptors (Mihic et al., 1997).
To characterize the M2–M3L of the muscle AChR, we
engineered a set of mutations in this region of the dif-
ferent subunits of adult mouse receptors and studied
their effects on the kinetics of activation of single
AChRs. Our results indicate that M2–M3L mutations af-
fect activation by selectively altering channel gating.
Furthermore, the results suggest that during channel
opening the M2–M3L of the 
 
a
 
 subunit moves before
the corresponding linkers of the 
 
b
 
 and 
 
e
 
 subunits.
 
METHODS
 
Mutagenesis and Expression
 
Mouse cDNA clones were obtained as described by Grosman and
Auerbach (2000a,b). The 
 
a
 
-subunit clone contained an inciden-
tal M4 mutation (V433A) that has no functional consequences
(Salamone et al., 1999). Mutations were engineered using either
the QuickChange™ Site-Directed Mutagenesis kit (Stratagene)
protocol or the cassette mutagenesis method (Sine, 1993). All
mutations were conﬁrmed by restriction mapping and dideoxy
sequencing. HEK-293 cells were transiently transfected by cal-
cium-phosphate precipitation (Ausubel et al., 1992; Salamone et
al., 1999). The medium was changed 
 
z
 
24 h after addition of the
calcium-phosphate precipitate, and electrophysiological record-
ings started 
 
z
 
24 h later.
 
Patch-Clamp Recordings and Analysis
 
Recordings were performed in the cell-attached patch conﬁgura-
tion (Hamill et al., 1981) at 
 
z
 
22
 
8
 
C. The pipette solution con-
tained (mM): 142 KCl, 5.4 NaCl, 1.8 CaCl
 
2
 
, 1.7 MgCl
 
2
 
, 10 HEPES/
KOH, pH 7.4. In most experiments using ACh, the bath solution
was the same as the pipette solution. In all other experiments, the
bath solution was Dulbecco’s phosphate-buffered saline (mM):
137 NaCl, 0.9 CaCl
 
2
 
, 2.7 KCl, 1.5 KH
 
2
 
PO
 
4
 
, 0.5 MgCl
 
2
 
, and 8.1
Na
 
2
 
HPO
 
4
 
, pH 7.3. Single-channel currents were ampliﬁed using a
patch-clamp ampliﬁer (PC-505; Warner Instrument Corp. or
200B; Axon Instruments, Inc.) and were digitized at 100 kHz.
To separate the more rapid binding and gating steps from the
slower desensitization steps, clusters of single-channel activity
were identiﬁed and used to estimate open probability (
 
P
 
open
 
),
time constants, and gating rate constants. Clusters were deﬁned
as a series of openings separated by closures shorter than a criti-
cal time, 
 
t
 
c
 
 (Sakmann et al., 1980). In the presence of ACh or low
concentrations of choline, 
 
t
 
c
 
 was determined as described by
Salamone et al. (1999). In the case of currents elicited with satu-
rating choline, 
 
t
 
c
 
 was the longest time interval that deﬁned clus-
ters still best ﬁtted with a C 
 
« 
 
O kinetic model, as described by
Grosman and Auerbach (2000b). Clusters of raw data were ideal-
ized according to either a half-amplitude threshold-crossing cri-
terion (program IPROC; Sachs et al., 1982) at a bandwidth of
 
z
 
4 kHz or a hidden-Markov-model–based algorithm (program
SKM) at a bandwidth of 
 
z
 
18 kHz. Only clusters whose overall
mean open time was within 
 
6
 
2 SD of the mean of the corre-
sponding patch were retained for further analysis (typically
 
.
 
98% of the original data; programs LPROC or SELECT).
 
Equilibrium concentration–response curves were analyzed in
the framework of Scheme I:
where C and O denote the closed and open channel, respec-
tively, A denotes the agonist, OA
 
2
 
B represents the open channel
blocked by the agonist itself, and CA
 
2
 
* is a shut state whose mean
lifetime is independent of the agonist concentration (Salamone
et al., 1999). In the presence of acetylcholine (ACh), the latter
has a mean duration of 
 
z
 
1 ms and is therefore distinct from the
long-lived desensitized state(s) that gives rise to the longer-lived
closed intervals between clusters. 
 
P
 
open
 
 values were estimated
from the idealized current traces as the fraction of time the chan-
nel is open within a cluster. Plots of 
 
P
 
open
 
 vs. agonist concentra-
tion were ﬁtted with Eq.1 to estimate the microscopic agonist-dis-
sociation equilibrium constant (
 
K
 
d
 
 
 
5 
 
k
 
2
 
/
 
k
 
1
 
) and the diliganded-
gating equilibrium constant (
 
u
 
2
 
 
 
5 b
 
2
 
/
 
a
 
2
 
):
 
(1)
 
where 
 
c
 
 
 
5 
 
K
 
B
 
/(
 
A
 
 
 
1 
 
K
 
B
 
) and 
 
K
 
B
 
 is the dissociation equilibrium
constant for channel block (
 
k
 
2
 
b
 
/
 
k
 
1
 
b
 
; 2 mM for ACh and 20 mM
for choline), and 
 
K
 
g
 
 is the equilibrium constant between 
 
OA
 
2
 
 and
 
CA
 
2
 
* (
 
k
 
1
 
g
 
/
 
k
 
2
 
g
 
; 0.05 for ACh, as in Salamone et al. (1999), and ig-
nored in the presence of choline). Eq. 1 corresponds to the clas-
sical sequential model (del Castillo and Katz, 1957; Magleby and
Stevens, 1972) modiﬁed for the case of two equivalent binding
sites, fast blockade by the agonist, and a short-lived desensitized
state (Salamone et al.,1999).
The opening rate constants of the various constructs in the
presence of ACh were estimated by ﬁtting plots of 
 
b9
 
 vs. agonist
concentration (
 
A) with the following empirical equation (Hill
equation, Eq. 2):
(2)
where b9 (the “effective” opening rate) is deﬁned as the recipro-
cal of the slowest component of the closed-time distribution, b2 is
the opening rate constant, A50 is the agonist concentration at
which b9 is half maximal (i.e., b2/2), and n is the Hill coefﬁcient.
b9 at each ACh concentration was estimated from the ﬁt of log-
binned (Sigworth and Sine, 1987) closed-time histograms with
sums of exponential densities. Likewise, mean open times in the
presence of ACh were estimated from the exponential ﬁt of log-
binned open-time histograms. Both closed- and open-interval his-
tograms were compiled from data idealized (half-amplitude crite-
rion) at an effective bandwidth of 4 kHz. The opening and clos-
ing rate constants in the presence of saturating 20 mM choline
were estimated, after idealization (program SKM), by applying a
full-likelihood algorithm that includes a correction for missed
events (program MIL; Qin et al., 1996, 1997). We used a one-step
C «O kinetic scheme, an effective bandwidth of z18 kHz, and a
dead time of z25 ms, as described by Grosman and Auerbach
(SCHEME I)
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(2000a,b). Because of the lengthening effect of fast blockade by
choline on the duration of openings, the closing rate constants
determined in this way are underestimations by a factor no
greater than 2 (Grosman and Auerbach, 2000b). As the single-
channel current amplitude was reduced to similar extents in both
wild-type and mutants (i.e., the afﬁnity for choline as a blocker is
largely unaffected by the mutations), the prolongation of the
openings is expected to be the same for all tested constructs.
The distribution of open times in the presence of low concen-
trations of ACh was analyzed in the context of an MWC-like ki-
netic model (Scheme II; Monod et al., 1965). This model incor-
porates the dissociation of agonist from the open channel as well
as openings of un- and mono-liganded receptors.
Where k2/k1 (5 Kd) and j2/j1 (5 Jd) are the microscopic ago-
nist-dissociation equilibrium constants from the closed and open
channels, respectively, b0/a0 (5 u0), b1/a1 (5 u1), and b2/a2 (5
u2) are the gating equilibrium constants of un-, mono-, and dili-
ganded receptors, respectively, k1D/k2D is the desensitization
equilibrium constant, and k1g/k2g is the equilibrium constant be-
tween OA2 and CA2*. Because this model was used to interpret
data recorded at low concentrations of ACh, blockade by the ago-
nist itself was ignored. According to Scheme II, to satisfy detailed
balance, u1 5 u0Kd/Jd and u2 5 u0(Kd/Jd)2.
Single-channel analysis programs of the QuB suite are available
at www.qub.buffalo.edu.
RESULTS
The SCCMS Mutation aS5I
The M2–M3 linkers of the different subunits of muscle,
neuronal, and Torpedo electroplaque AChRs are all 15
amino acids long and contain several conserved resi-
dues, including two Pro (Table I). The homology be-
tween aligned residues is largely lost, however, when
the anion-selective members of the superfamily of nico-
tinoid receptors (GABA and glycine receptors) are in-
cluded in the comparison, although the ﬁrst Pro is still
present.
The naturally occurring mutation aS269I (position 5
in our numbering system; aS5I) causes a congenital
myasthenic syndrome (Croxen et al., 1997). Example
single-channel currents from recombinant mouse aS5I
AChRs in the presence of 0.2 mM ACh are shown in
Fig. 1. The open-interval duration histogram (270 mV;
4 kHz) was best ﬁtted with two exponential compo-
(SCHEME II)
nents, the mean of the slowest being z4.5 ms. In the
wild type, under otherwise identical experimental con-
ditions, the mean of the slowest (and predominant)
component was z0.75 ms (Table II).
At an effective bandwidth of z4 kHz, the minimum
detectable time using the “half-amplitude” idealization
criterion is z45 ms (Colquhoun and Sigworth, 1995)
and, therefore, in wild-type AChRs, only z1% of the
brief sojourns in the diliganded closed state (z10 ms
on average) are detected. As a consequence, apparent
open intervals often include two or more consecutive
openings and, therefore, are not true estimates of the
reciprocal of the diliganded closing rate constant. Tak-
ing the sequential model (Scheme I) as an approxima-
tion of the channel’s kinetic behavior, and neglecting
the (short) time spent in the closed diliganded state
(CA2), the mean duration of the slowest component of
these apparent openings is given by:
 (3)
where (1 1 b2/2k2) is the mean number of openings
per burst. In the experiments at low concentrations of
ACh, the probability that sojourns in shut states other
than CA2 were shorter than the time resolution of 45 ms
(and thus that were included within an apparent open-
ing) is negligible. Likewise, the probability that a so-
journ in CA2 was longer than 45 ms (and thus that ter-
minates an apparent opening) is vanishingly small. In
conclusion, an “apparent opening,” deﬁned as a series
of openings separated by closures shorter than 45 ms, is
likely to reﬂect a sojourn in the combined set of states
(CA2 1 OA2).
From Eq. 3, it can be seen that the prolonged open-
time constant of aS5I AChRs may arise from one or a
combination of the following: an increased opening
rate constant (b2), a decreased closing rate constant
(a2), or a decreased agonist-dissociation rate constant
(2k2). To distinguish between these possibilities, we
studied the effect of the aS5I mutation on gating by us-
ing choline as the agonist. Choline slows channel gat-
ing so open and closed intervals can be fully resolved
(Grosman and Auerbach, 2000b). Fig. 2 shows clusters
of single-channel currents of aS5I AChRs recorded in
saturating 20-mM choline. The opening rate constant
(b2) was 7,098 6 1,227 s21, and the closing rate con-
stant (a2) was 1,487 6 313 s21. These are, respectively,
27.73 faster and 3.333 slower than those of wild-type
AChRs activated by choline (Grosman and Auerbach,
2000b). Thus, with choline as the agonist, the aS5I mu-
tation increases the gating equilibrium constant z92-
fold, mostly due to an increase in b2.
Next, we sought to determine whether the aS5I mu-
tation affects binding afﬁnity. Single-channel currents
elicited over a range of choline concentrations were re-
to
1
a2
------ 1
b2
2k2
--------- + èø
æö , @330 The Extracellular Linker of Acetylcholine Receptor Channels
corded, and intracluster Popen values were estimated
and compared with that of ACh (Fig. 2). The lower efﬁ-
cacy (i.e., smaller u2) of choline allowed us to ﬁt the
Popen-vs.-concentration data with Eq. 1, yielding u2  5
b2/a2 5 2.5 6 0.9 and Kd 5 k2/k1 5 3.3 6 1.4 mM.
This value of u2 is consistent with the rate constants ob-
tained by single-channel kinetic modeling of currents
elicited by 20-mM choline with a KB of 20 mM and as-
suming a sequential model for channel block. The Kd
for wild-type AChRs activated by choline is not known
with certainty because the extremely low efﬁcacy of this
agonist makes this dose–response curve difﬁcult to
measure. However, the wild-type Kd is in the millimo-
lar range (Zhou et al., 1999). Thus, the choline dose–
response results suggest that the aS5I mutation does
not substantially alter the afﬁnity of the closed-channel
transmitter binding site for choline, but rather pre-
dominantly affects channel gating.
The gating (u2) and agonist dissociation (Kd) equilib-
rium constants of ACh-activated receptors could not be
directly estimated from the dose–response data (by ﬁt-
ting Eq. 1) because of the high ACh u2 value. However,
the Popen-vs.-concentration relationship of the aS5I mu-
tant activated by ACh revealed an EC50 of z4.0  mM,
TABLE I
M2–M3 Linker-sequence Alignment of the Members of the Superfamily of Nicotinoid Receptors
Subunit 22 21 0 1234567 8 9 1 01 1 1 2
m/hAChRa EL I P STSSAV P LI GK
tAChRa EL I P STSSAV P LI GK
m/hAChRb DK V P E T S L A/S V P II IK
tAChRb DK V P ETSLSV P II IR
m/hAChRd KR L P ATSMAI P L V/I G K
tAChRd QR L P ETALAV P LI GK
m/hAChRg KK V P ETSQAV P LI SK
tAChRg QK V P ETSLNV P LI GK
m/hAChRe QK I P ETSLSV P LL GR
hAChRa2E I I P STSLVI P LI GE
hAChRa3E T I P STSLVI P LI GE
hAChRa4E I I P STSLVI P LI GE
hAChRa5E I I P SSSKVI P LI GE
hAChRa6E T I P STSLVV P LV GE
hAChRa7E I M P ATSDSV P LI AQ
chAChRa8E I M P ATSDSV P LI AQ
hAChRa9E I M P AS —ENV P LI GK
hAChRb2K I V P PTSLDV P LV GK
hAChRb3E I I P SSSKVI P LI GE
hAChRb4K I V P PTSLDV P LI GK
h5-HT3A DT L P ATA IGT P LI GV
h5-HT3B NQ V P RSVGST P LI GH
m/hGlyRa1–4 A S L P KVSYVK A ID IW
hGlyRb AE L P KVSYVK A LD VW
hGABAAa1–6 N/H S L P K V A/S Y A/L T A M D W F
hGABAAb1–3 E T L P K I P Y V K A I D I/M Y
r/hGABAAg1–3 K S L P K/R V S Y V T A M D L F
hGABAAd SS L P RASA IK A LD V Y
hGABAAe KN F P RVSY IT A LD F Y
hGABAAp TS L P NTNCFI K AI DV
hGABACr1–2 A S M P R V S Y I-V K A V D I Y
Position 22 marks the putative beginning of the M2–M3 linker for ACh and serotonin (5-HT3) receptors. In glycine and GABA receptors, this domain
presumably starts one residue before (position –3) being an R in GlyRa1–4 and all GABAA receptor subunits, an A in the GlyRb subunit, and an N in both
GABACr subunits. A Pro residue occupies the fourth or fifth position in all members of the superfamily and is assigned the number 1, according to our
numbering system. The putative end of this linker is at position 12 in Ach, 6 in 5-HT3, 10 in glycine, and 7–8 in GABA receptors. The sequences and putative
topology of all subunits were taken from the SWISS-PROT Protein Sequence Database, with the exception of AChR a8 (Schoepfer et al., 1990), 5-HT3A,
and 5-HT3B (Davies et al., 1999). Whenever available, the human (h) sequences are given; otherwise, the sequences of either chicken (ch), mouse (m), or
rat (r) are indicated. The M2–M3 linker sequences of the human a, b, d, and e AChR subunits are almost identical to those of mouse (the clones used in
this paper). Torpedo (t) sequences are also included.331 Grosman et al.
which is z103 lower than that of the wild type deter-
mined under identical conditions (Salamone et al.,
1999). According to Eq. 1, when the gating equilibrium
constant is large  Therefore,
the  z10-fold decrease in ACh EC50 can be accounted for
by an z100-fold increase in u2, which is similar to the 92-
fold increase in u2 measured in the presence of choline.
These results indicate that u2 is increased to the same ex-
tent in the presence of ACh or choline. An increase in u2
can arise from an increase in the unliganded gating
equilibrium constant, u0 (b0/a0) and/or an increase in
the closed/open agonist-afﬁnity ratio, Kd/Jd (Scheme
II). The agonist-insensitive effect of the aS5I mutation
on u2 suggests that this mutation increases the unli-
ganded gating equilibrium constant with little, if any, ef-
fect on the afﬁnity ratio, which is expected to be sensitive
to the nature of the agonist. Several SCCMS mutations,
including aS5I, have been shown to increase unliganded
gating, thus turning choline, a normally inert molecule,
into a signiﬁcant agonist (Zhou et al., 1999).
q2 1 » () EC50 Kd q2 ¤ . @ ,
Although gating of aS5I receptors in the presence of
ACh is exceedingly fast for the rate constants to be mea-
sured directly, the closing and opening rate constants
can be predicted based on the results in the presence of
choline. This is because the structure of the AChR at
the transition state of the gating reaction is likely to be
the same regardless of the particular ligand bound
(Grosman et al., 2000). Thus, like in the presence of
choline, we estimate that ACh-bound aS5I receptors
open  z27.73 faster, and close z3.333 slower, than the
wild type; i.e., b2 > 1.4 106 s21 and a2 > 750 s21.
Even though the predicted value of b2 cannot be con-
ﬁrmed experimentally from the duration of shut inter-
vals, the effect that such a fast opening rate constant
would have on the apparent open-time distribution can
be calculated. In particular, we focused on the time con-
stant of the slowest component of the distribution (to),
which, for Scheme I, is approximately given by Eq. 3 at
any concentration of agonist. According to this equa-
tion, to for the aS5I mutant should be 48 ms, which is
more than 103 longer than the observed to of z4.5 ms.
However, as b2 increases and a2 decreases, the se-
quential-model simpliﬁcation (Scheme I and Eq. 3) be-
comes inappropriate because the probability that a
burst of openings terminates from the open state (i.e.,
by agonist dissociation from the open state followed by
closing or by directly entering a desensitized state) is
no longer negligible. Accordingly, an MWC-like kinetic
model (Monod et al., 1965; Scheme II) was used to in-
terpret  to values. Considering Scheme II, it can be
shown that to (the slowest component of the open-time
distribution) is an increasing function of agonist con-
centration whose value at inﬁnite agonist concentra-
tion is given by Eq. 3, and at zero agonist concentration
(our conditions, approximately) by Eq. 4:
Figure 1. Open-interval prop-
erties of wild-type (WT) and aS5
mutant AChRs. Currents were re-
corded in the presence of 0.2
(aS5I, aS5C, and aS5F) or 1 (all
other constructs) mM ACh. (A)
The slowest open-time constant
of each construct is indicated
as the mean 6 SD of three to
six patches. (B) Example open-
interval histograms, superim-
posed density functions, and sin-
gle-channel currents. Histograms
were best ﬁtted with two (aS5I,
aS5C, and aS5F) or one (all
other constructs) exponential
component. No correction for
missed events was made. Pipette
potential  >  170 mV. Analysis
and display fc > 4 kHz. Openings
are downward deﬂections.
TABLE II
Experimental to Values of M2–M3L Mutant AChRs Activated by ACh
Mutant to SD Mutant to SD Mutant to SD
ms ms ms
Wild type 0.75 0.21 aS5K 0.84 0.03 bL5I 0.56 0.11
ADD 1.46 0.05 aS5Q 0.60 0.10 eS4I 6.60 0.90
DEL 0.28 0.05 aS5I 4.50 0.30 eL5S 1.20 0.20
aT3A 0.16 0.04 aS5C 7.50 0.30 dT3I 0.51 0.06
aT3I 0.17 0.03 aS5F 7.40 0.80 dS4I 0.65 0.05
aS4A 1.20 0.20 aA6S 0.71 0.05 dM5S 0.68 0.07
aS4I 0.36 0.03 aV7A 0.74 0.04 dM5I 0.94 0.15
aS5A 0.79 0.08 bS4I 9.10 0.90 dA6I 1.01 0.14
aS5D 0.61 0.06 bL5S 1.02 0.02332 The Extracellular Linker of Acetylcholine Receptor Channels
(4)
where s is the sum of all the rate constants leading
away from OA2 other than a2. These are the dissocia-
tion rate constant from the diliganded open channel
(2j2), the rate constant leading to the long-lived desen-
sitized state (k1D), and the rate constant leading to
CA2* (k1g).
Using the wild-type value of 40,000 s21 for 2k2 (Akk
and Auerbach, 1996; Wang et al., 1997; Salamone et al.,
1999), it can be calculated from Eq. 4 that a s value of
200 s21 accounts for all three experimental observa-
tions in the presence of ACh: (a) a to value of 0.75 ms
for the wild type; (b) a to value of 4.5 ms for the mutant
at low ACh concentration, and (c) an z10-fold smaller
EC50 for the mutant. We were unable to ﬁnd other com-
binations of b2, a2, 2k2, and s values that could account
simultaneously for these three ﬁndings.
Mutational Analysis of Position a5
The aS5I mutation increases both the hydrophobicity
and size of the side chain. To further characterize the
structure–function relationships of this position, we
engineered a series of polar and hydrophobic side
chains at a5 (Fig. 1 and Table II). Using ACh as the ag-
onist, hydrophobic substitutions (Phe, Cys) increased
to nearly 10-fold, while polar substitutions (Asp, Gln,
and Lys) were without effect. Ala, which has the highest
to s 1
1
a2
------ 1
b2
2k2
--------- + èø
æö
------------------------------- +
1 –
, @
mutational probability with Ser, also yielded wild-type-
like to values.
Some of these aS5 mutants were also studied using
choline as the agonist (Fig. 3 A). The aS5C mutation
had essentially the same effect as the aS5I mutation;
that is, it produced a large increase in the opening rate
constant (26-fold) and a modest decrease in the closing
rate constant (3.7-fold). The aS5Q mutant was similar
to the wild type, with essentially no change in the open-
ing (z1.3-fold increase) or closing (z1.2-fold increase)
rate constants. For both mutations, to values were cal-
culated using Eq. 4 with 2k2 5 40,000 s21 and s 5 200
s21, assuming that only b2 and a2 change upon muta-
tion. For aS5C and aS5Q receptors, the calculated val-
ues were z4.5 and 0.77 ms, respectively, in reasonable
agreement with the experimental values of 7.5 and 0.6
ms (Table II).
The similarity of the effects of S/Q and C/I residues
suggests that the volume of the a5 sidechain (z89 and
z144 Å3 for S and Q, and z109 and z167 Å3 for C and
I, respectively; Zamyatnin, 1972) is not a signiﬁcant fac-
tor with regard to channel gating. The overall results
suggest that a hydrophobic residue in position a5 in-
creases the AChR gating equilibrium constant.
Mutational Analysis of the a-subunit M2–M3L Domain
To further explore the role of the M2–M3L in gating, we
made additional mutations at different positions of the a
subunit (Fig. 4 and Table II). Both T ® A and T ® I mu-
tations at position a3 shortened to of ACh-gated currents
by a factor of z4.5 (0.16–0.17 vs. 0.75 ms in the wild type).
Figure 2. Single-channel prop-
erties of wild-type and aS5I
AChRs. (A) Single-channel clus-
ters in the presence of 20-mM
choline. Display fc  > 6 kHz.
Openings are downwards. Cali-
bration bar: 47 ms for wild-type
and 13 ms for aS5I receptors.
(B) Monoexponential dwell-time
histograms and superimposed
density functions of currents elic-
ited by 20-mM choline. Analysis
fc 5 18 kHz. The aS5I mutation
speeds up channel opening
more than it slows down channel
closing. (C) Equilibrium concen-
tration–response curves of aS5I
receptors in the presence of ACh
(s) or choline (d). The former
was ﬁtted with a straight line; the
latter was ﬁtted with Eq. 1. The
dashed line corresponds to the
dose–response curve expected
from the wild-type channel in the
presence of ACh.333 Grosman et al.
For these mutations, kinetic modeling of single-channel
clusters elicited by ACh was possible because the opening
rate constant was slower than the wild type’s and, there-
fore, the use of choline was not needed. b2 was reduced
from z50,000 s21 in the wild type to 2,127 s21 and 1,730
s21 in the Ala and Ile mutants (Fig. 5), whereas a2 in-
creased from 2,500 s21 in the wild type to z6,000 s21 in
both mutants. Thus, the consequences of these aT3 muta-
tions are nearly opposite to those of the aS5I mutation;
i.e., b2 decreases z26-fold and a2 increases z2.4-fold. The
net effect of these mutations is to decrease u2 by z62-fold.
Returning to Eq. 4, the shorter to in aT3A and aT3I
AChRs mainly reﬂects a reduced number of openings per
burst (because of a much smaller b2). Like mutations at
position a5, mutations of a3 residues also had a larger ef-
fect on channel opening than on channel closing.
The dose–response properties of aT3I and aT3A ac-
tivated by ACh are shown in Fig. 5. The Kd values of
these two mutants for ACh were similar to that of the
wild type, while the u2 values were smaller. This result is
consistent with the suggestion that the nearby mutation
aS5I does not alter the Kd. Together, these results sug-
gest that the M2–M3L of the a subunit is not an impor-
tant determinant of agonist afﬁnity.
We next studied the effect of S ® A and S ® I muta-
tions of the a4 residue. With ACh as the agonist, aS4A
AChRs had a to of z1.2 ms, which is not very different
from that of the wild type, while the aS4I mutant had a
to of z0.36 ms (Fig. 4 and Table II). Further kinetic and
dose–response analyses of the aS4I mutant in the pres-
ence of ACh are shown in Fig. 5. b2 > 1,500 s21, which is
.303 slower than the wild-type’s value. In this regard,
aS4I resembles the aT3I mutant. Unlike the a3 mutant,
however, a2 > 2,777 s21, which is similar to that of the
wild type. Again, mutations at the a4 position mostly af-
fect the channel opening rate constant. Dose–response
analysis of aS4I indicates that this mutation decreases
the Kd, but less than approximately threefold (Fig. 5).
In summary, positions 3, 4, and 5 of the M2–M3L of
the a subunit were probed using mutagenesis. Muta-
Figure 3. Transition-state map-
ping at position a5. (A) Single-
channel currents of wild-type and
aS5 mutant AChRs in the pres-
ence of 20-mM choline. Display
fc > 6 kHz. Openings are down-
wards. Calibration bar: 40 ms for
wild-type and aS5Q, and 13 ms
for aS5I and aS5C. (B) Brønsted
plot of the four constructs. The
slope, F, is 0.694 6 0.028.
Figure  4. Open-interval prop-
erties of a-subunit M2–M3L mu-
tants in positions other than a5.
Currents were recorded in the
presence of 5 (aT3A and aT3I)
or 1 (all other constructs) mM
ACh. (A) The slowest open-time
constant of each construct is in-
dicated as the mean 6 SD of
two (aV7A,  aS4I, and aADD)
or three (all other constructs)
patches. (B) Example open-inter-
val histograms, superimposed
density functions, and single-
channel currents. Histograms
were best ﬁtted with one expo-
nential component. No correc-
tion for missed events was made.
Pipette potential >  170 mV.
Analysis and display fc > 4 kHz.
Openings are downwards.334 The Extracellular Linker of Acetylcholine Receptor Channels
tions in this region mainly affect channel gating with
little effect on agonist binding. Hydrophobic substitu-
tions at position 5 increase, and at positions 3 and 4 de-
crease, the channel opening rate constant.
The M2–M3L Domain in Other Subunits
In the b and e subunits, an S ® I mutation in position 4
produced channels having prolonged to values. With
ACh as the agonist, to was z9.1 ms for bS4I and 6.6 ms
for eS4I AChRs, respectively (Fig. 6). Again, we quanti-
ﬁed the effects of the mutations on the opening and
closing rate constants using choline as the agonist (Fig.
7). For bS4I, b2 was z3.9-fold faster and a2 was z6.1-
fold slower than the wild type (u2 increased z23.5-
fold). The effect of eS4I was less pronounced, as b2 was
only z2.8-fold faster and a2 was z2.2-fold slower than
in the wild type (u2 increased approximately sixfold).
Application of Eq. 4 assuming that only t0 changes
upon mutation and using a s value of 200 s21 yields to
values of 3.7 and 2.2 ms for the bS4I and eS4I mutant
receptors, respectively.
The dS4I mutation did not affect channel gating. We
scanned nearby residues in d by mutation to Ile, and
none yielded AChRs having prolonged to values (Fig. 6
and Table II).
Change in the Length of the M2–M3L
To explore the effect of changes in length, we engi-
neered  a-subunit mutants having longer or shorter M2–
M3L regions. Decreasing the linker size by one residue
Figure 5. Equilibrium concen-
tration–response curves for wild-
type and representative M2–M3L
mutant AChRs in the presence of
ACh. (A) Intracluster Popen as a
function of ACh concentration
was ﬁtted with Eq. 1. (B) The ef-
fective opening rate (b9) as a
function of ACh concentration
was ﬁtted with Eq. 2. (d) wild
type, (*) aS5D, (m)  aS4I, (r)
aT3A, (1) aT3I.
Figure 6. Open-interval prop-
erties of b-, d-, and e-subunit M2–
M3L mutants. Currents were re-
corded in the presence of 0.2
(b-, d-, and e-subunit mutants) or
1 (wild-type) mM ACh. The slow-
est open-time constant of each
construct is indicated as the
mean  6 SD of three patches.335 Grosman et al.
shortened to (z0.28 ms), while adding one residue
lengthened it (z1.46 ms) (Fig. 4 and Table II). The
briefer  to of the deletion mutant suggests that b2 is slower
and a2 is z1.5-fold faster when the M2–M3L is shorter.
The to of the addition mutant suggests that b2 is faster,
and/or a2 is slower, when the M2–M3L is longer.
Mapping the Gating Transition State at the M2–M3L
To probe the closed-like-vs.-open-like character of the
M2–M3L at the gating transition state, we examined
the correlation between rate and equilibrium constants
of the gating reaction for the side-chain series at posi-
tions a3 (S, A, and I), a4 (S and I) and a5 (S, Q, C, and
I). A linear correlation (“linear free-energy relation-
ship;” Lefﬂer and Grunwald, 1963) is expected to hold
when the conformation of the mutated region of the
protein at the transition state is intermediate between
the conformations in the open and closed states (Gros-
man and Auerbach, 2000b; Grosman et al., 2000). The
slope of the Brønsted plot (log rate constant vs. log
equilibrium constant), F, is a measure of how “open”
the probed region is when the transition state is
reached, with F 5 0 being fully closed and F 5 1 being
fully open.
For the a3 position, F 5 0.789 6 0.010 in the pres-
ence of ACh (the correlation coefﬁcient between log b
and log a is 0.985). For the a4 position, F 5 0.971 in
the presence of ACh as well (two-point relation). For
the a5 position, F 5 0.694 6 0.028 in the presence of
choline (Fig. 3 B; the correlation coefﬁcient between
log b and log a is 0.988). These results suggest that the
conformation of the region around aS3-5 at the transi-
tion state of the gating allosteric transition is $70%
open-like (#30% closed-like). It is important to note
that F values are likely to be insensitive to the nature of
the particular ligand used as the agonist (Grosman et
al., 2000) and, therefore, that F values estimated in the
presence of choline are good estimates of the corre-
sponding values in the presence of ACh.
F values of the b4 and e4 positions were calculated
from two-point relations. With choline as the agonist,
these values were 0.431 in b and 0.568 in e. The F value
corresponding to the d subunit, however, could not be
measured because none of the tested mutations in the
M2–M3L of this subunit caused a signiﬁcant change in
the gating equilibrium constant.
DISCUSSION
aS5I Is a Typical SCCMS Mutant
Like many other SCCMS mutants (Sigurdson and Auer-
bach, 1994; Ohno et al., 1995), aS5I AChRs have a pro-
longed apparent open time (Table II), an increased sen-
sitivity to the metabolite choline (Fig. 3 A and Zhou et
al., 1999), and an increased spontaneous activity (Zhou
et al., 1999). Our results suggest that the afﬁnity ratio is
largely unaffected by the aS5I mutation and, therefore,
that the increased gating in the presence of ACh can be
accounted for by a more favorable isomerization step
(an increased unliganded gating equilibrium constant).
Although the term “slow channel” that describes the
SCCMS phenotype refers to the slow decay of the end-
plate current, the predominant underlying mechanism
of the disease is the accelerated channel opening: aS5I
AChRs are hyperactive channels that open too fast.
Along similar lines, “fast-channel” congenital myas-
thenic syndromes (e.g., eP121L; Ohno et al., 1996) are
caused by sluggish AChRs that open too slowly.
Mechanistic Basis of the SCCMS Phenotype of aS5I Receptors
It is difﬁcult to analyze the kinetic and dose–response
properties of AChRs that open extremely rapidly, such
as  aS5I. The brevity of sojourns in the closed dili-
ganded state results in many missed closures, and this
distortion of the data makes it impossible to estimate
binding and gating rate constants directly from the
dwell-time series. Moreover, in these cases, the gating
equilibrium constant is very large, hence the estimates
of gating (u2) and agonist-dissociation (Kd) equilibrium
constants obtained by ﬁtting Popen-vs.-concentration
curves are ill-determined (i.e., have large coefﬁcients of
variation).
Another consequence of a very fast opening rate con-
stant is that the EC50 value may no longer depend on the
agonist afﬁnity for the closed state of the receptor. Ac-
cording to Scheme II, when 
where Jd is the microscopic dissociation equilibrium
constant from the open state.
To overcome the limitations imposed by using ACh
as the agonist, we analyzed the single-channel behavior
of the aS5I mutant in the presence of choline, a low-
q2 1 » EC50 Jd @q 0 ¤ () , ,
Figure 7. Example single-channel clusters of bS4I and eS4I mu-
tants in the presence of 20-mM choline. Display fc > 6 kHz. Open-
ings are downwards.336 The Extracellular Linker of Acetylcholine Receptor Channels
efficacy agonist that opens the channel relatively slowly.
In the presence of choline, we found that the mutation
affects gating (z28-fold increase in b2, z3.3-fold de-
crease in a2) while having little effect on agonist afﬁnity
for the closed state. The latter was also suggested by the
analysis of Popen-vs.-ACh concentration data of nearby
mutations that decrease u2 (aT3I, aT3A, and aS4I). Be-
cause the mutation increases the gating equilibrium
constant to the same extent regardless of whether ACh
or choline is bound to the receptor, we also suggest that
the agonist afﬁnity for the open channel is largely unaf-
fected. These results clearly indicate that the predomi-
nant effect of the aS5I mutation is to favor the chan-
nel’s isomerization step.
The observed prolongation of to in the presence of
ACh by the aS5I mutation was similar to the value pre-
dicted using Eq. 4, with s equal to 200 s21. Considering
that open channels desensitize at a rate ,10 s21 (Auer-
bach and Akk, 1998) and enter the CA2* state (see
Scheme II) at a rate of z50 s21 (Salamone et al., 1999),
then ligand dissociation from the diliganded open state
would occur at a rate of z140 s21; that is, z70 s21 from
each binding site if they were equivalent. This value is
z3003 slower than the dissociation rate constant from
the closed conformation, and (only) about three times
faster than the dissociation rate constant from the de-
sensitized state (Auerbach and Akk, 1998).
Previous estimates of the agonist-dissociation rate
constant from diliganded open AChRs consisted of cal-
culations in the context of cyclic kinetic schemes, as-
suming microscopic reversibility and identical associa-
tion rate constants of the agonist to the closed and
open conformations. For ACh, values of 0.2 s21 for
adult-type (a2bde; Edelstein et al., 1997) and 17.3 s21
for fetal-type receptors (a2bdg; Edelstein et al., 1996)
can be found in the literature. Values of 0.02 s21 for
suberyldicholine bound to adult-type AChRs (Colqu-
houn and Sakmann, 1985) and 40 s21 for carbamylcho-
line bound to fetal-type AChRs (Jackson, 1988) have
also been reported.
Applying a similar approach, we can calculate the dis-
sociation rate constant from diliganded open channels
using published values of the agonist-dissociation rate
constant from diliganded closed channels and the
equilibrium constants of mono- and diliganded gating.
For ACh bound to adult-type AChRs, values include 3.7
s21 (from data in Ohno et al., 1996) and 96.5 s21 (from
data in Wang et al., 1997).
The reason for the disparity of these estimates is not
clear, but is most likely related to inaccuracies in the
identiﬁcation of monoliganded openings (Lingle et al.,
1992). Our approach, although having its own caveats,
is an alternative one that not only avoids this pitfall, but
also relieves the constraint of equal ACh-association rate
constants to the closed and open forms of the channel.
Taken together, our results suggest that aS5I receptors
can open as fast as at z1.4 3 106 s21. Experiments with
other very-fast-opening mutants, as well as conﬁrmation
of the s value estimated here, are needed to explore the
issue of a speed limit for AChR gating. An upper limit of
108 s21 has been proposed for the T ® R conformational
change of hemoglobin (Eaton et al., 1991) and of 106 s21
for protein folding (Hagen et al., 1996).
Mutational Analysis of the M2–M3L Domain
The results indicate that the hydrophobic amino acids
Phe, Cys, and Ile at the a5 position increase the dili-
ganded gating equilibrium constant and produce the
SCCMS phenotype. The less hydrophobic residues Asp,
Lys, Gln, Ala, and Ser result in wild-type–like gating. As
noted before, the large variation in the size of these
side chains indicates that residue volume is not a signif-
icant factor with regard to gating. It is also interesting
that the a5 mutants have either a wild-type or an SCCMS-
like phenotype, in spite of the variety of residues tested.
Taken alone, this pattern would suggest that the local
environment of aS5 changes from polar to nonpolar
upon channel opening.
It is remarkable that similar modiﬁcations to adjacent
residues in the M2–M3L have such diverse effects on
gating. As opposed to the effect of S ® I and S ® A mu-
tations at position a5, similar substitutions at positions
a3 (T ® I and T ® A) or a4 (S ® I) impair gating (i.e.,
decrease  u2), making the interpretation of the struc-
ture–function results less straightforward. This suggests
a marked dependence of the effect of mutations on the
position in the primary sequence of the M2–M3L. This
pattern is different from that of other regions of the
AChR like M2, where, regardless of the position, muta-
tions have either little effect or favor (rather than im-
pair) gating (e.g., Labarca et al., 1995; Grosman and
Auerbach, 2000a,b).
The effect of M2–M3L mutations was different in the
different subunits even though they were at positions
that were homologous in terms of sequence. Even
though mutations in b and e yielded AChRs with in-
creased u2 values, characteristic of the SCCMS pheno-
type, position 4 was more sensitive to mutation than po-
sition 5, as opposed to the situation in the a subunit.
Also, the to values for the b- and e-subunit mutants pre-
dicted by Eq. 4, assuming that only u0 changes upon
mutation and a value of 200 s21 for s, differ from the
experimentally derived to values. More experiments
are needed to determine the agonist-binding proper-
ties of the b and e M2–M3L mutants. Interestingly, mu-
tations at positions d3–6 did not have any effect on
channel gating whatsoever. Thus, we conclude that, in
the M2–M3L, homology in sequence does not coincide
with homology in function. It is unlikely that this inter-
pretation is caused by the vagaries of primary-structure337 Grosman et al.
alignment because the M2–M3L motif is very well con-
served (Table I). That mutations in the d subunit do
not affect gating is yet additional evidence for the dis-
tinct role of this subunit in the receptor’s function
(Grosman and Auerbach, 2000a,b).
Physical Mechanism
It is remarkable that the gating behavior of the a-sub-
unit M2–M3L mutants was trimodal, being either that of
the wild type (aS5D, aS5K, and aS5A), of the SCCMS
mutant aS5I (aS5I, aS5C, and aS5F), or of the aT3
mutants (aT3A, aT3I, and aS4I). Considering that
these side chains cover a rather wide range of physico-
chemical properties, we would have expected to ob-
serve a continuum of gating phenotypes if the local en-
vironment of the side chains themselves had been a
critical determinant of the gating equilibrium constant.
Instead, the modality of the results suggests that the
mutations cause the M2–M3L as a whole to adopt one
of at least three conformations, each leading to a dis-
crete phenotype.
M2–M3L Mutations in Other Receptors
Mutations of the M2–M3L domain have been studied
in other ionotropic receptors. In glycine receptors,
these have been shown to selectively impair gating (ac-
cording to our numbering system: a1 R-3L, a1 R-3Q, a1
K2E, and a1 Y5C; Lynch et al., 1997), a conclusion that
was conﬁrmed by single-channel analysis of the a1 K2E
mutant (Lewis et al., 1998). These results are similar to
ours for the a3 position of muscle AChRs. In GABAC re-
ceptor r1 homomers, the R2A mutation (Kusama et al.,
1994) increases the diliganded gating equilibrium con-
stant, a result that is similar to ours for the S ® I muta-
tions at positions a5, b4, and e4 of the muscle AChR.
Mutation of position 5 of the neuronal AChR subunits
a3, a7, or position 6 of b4 impair gating without affect-
ing binding (Campos-Caro et al., 1996; Rovira et al.,
1998, 1999).
In summary, the M2–M3L is an important domain
with regard to channel gating. However, whether it acts
as the crucial transduction element between the bind-
ing sites and the pore, as it has often been suggested
(e.g., Lynch et al., 1997), remains an open question.
Mutagenesis data indicate that substitutions almost ev-
erywhere in the protein (including the binding sites)
can affect the gating allosteric transition in the same
way as those in the M2–M3L. This supports the notion
that regions throughout the entire receptor are in-
volved in the gating conformational change.
The M2–M3L and the Gating Reaction Pathway
Through F value analysis (Fersht, 1999; Grosman et al.,
2000), we estimated the position of the transition state
along the gating-reaction pathway measured at the M2–
M3L of the a, b, and e subunits. In the a subunit, F $
0.7. This suggests that, during the opening reaction,
the closed ® open conformational rearrangement of
this domain is .70% complete at the transition state
(or ,30% complete when going in the open ® closed
direction). In the e and b subunits, however, F was
found to be z0.57 and z0.43, respectively. F values
have been suggested to reﬂect the sequence of confor-
mational rearrangements with the movement of re-
gions having larger F values preceding those with
smaller ones (Itzhaki et al., 1995; Villegas et al., 1998;
Ternström et al., 1999; Grosman et al., 2000). Insofar as
the M2–M3L residues of all subunits occupy similar lo-
cations in the quaternary structure of the AChR, this re-
sult suggests that the a subunit leads the conforma-
tional change in the opening direction, being followed
by e, and then by b, at least as far as the M2–M3L do-
mains are concerned.
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